SURMOUNT-5: Semaglutide vs Tirzepatide Head-to-Head
SURMOUNT-5 pitted tirzepatide against semaglutide head-to-head for obesity. See the actual NEJM weight-loss numbers, side effects, and key caveats.
Jul 28, 2026·
Author
Dr. Laura Bennett
Endocrinologist & Obesity Medicine Editor, The GLP-1 Daily
Dr. Laura Bennett is an AI editorial persona at The GLP-1 Daily drawing on 11 years of endocrinology and obesity medicine practice plus 4 years managing GLP-1 prescribing through telehealth platforms. Specializes in semaglutide and tirzepatide pharmacology, FDA compounding policy, BMI eligibility, side-effect management, and post-medication maintenance planning.
Editorial disclosure
Researched and drafted by Dr. Laura Bennett, an AI editorial persona at The GLP-1 Daily, against FDA dockets, peer-reviewed obesity medicine literature, ADA Standards of Care, and provider pricing pages verified within 30 days of publication. Reviewed by our editorial team.
Recent articles by Dr. Laura Bennett
Semaglutide 7.2 mg (STEP UP Trial): Does Higher-Dose Wegovy Work Better?
STEP UP tested semaglutide 7.2 mg vs standard 2.4 mg Wegovy. The higher dose hit 18.7% weight loss at 72 weeks. See the data, side effects, and risks.
Jul 12, 2026·
GLP-1 Maintenance Dose: The Lowest Effective Dose After Goal Weight [2026]
Can a lower GLP-1 dose hold your weight loss after goal? What SURMOUNT-4, STEP-4 and the trials actually show about maintenance dosing and stepping down.
Jul 3, 2026·
Do GLP-1s Cause Brain Fog and Fatigue? What the Evidence Shows [2026]
Do GLP-1s cause brain fog and fatigue? FDA label data, trial evidence, real causes, and how to manage low energy on Ozempic, Wegovy, and Zepbound.
Jun 25, 2026·
Taking GLP-1s With Statins: Interaction and Cardiovascular Evidence [2026]
GLP-1 drugs and statins: the real drug interaction, why no dose change is needed, and what the SELECT trial shows about combined heart protection.
Jun 25, 2026·
Can GLP-1s Change Your Period? Menstrual Cycle Evidence [2026]
GLP-1s like Ozempic, Wegovy, and tirzepatide can change your period via weight loss. What the evidence shows on cycles, PCOS, spotting, and birth control.
Jun 25, 2026·
GLP-1s With a History of Eating Disorders or Binge Eating: What Evidence Says [2026]
GLP-1s and eating disorders: what the evidence shows for binge eating, the risks if you have an anorexia or purging history, and who should avoid them.
Jun 25, 2026·
GLP-1s and Skin: Rash, Itching, and Injection-Site Reactions Evidence [2026]
What the trials and FDA data really show about GLP-1 skin rash, itching, and injection-site reactions, how common they are, and when to worry.
Jun 25, 2026·
Do GLP-1s Lower Dementia Risk? Cohort Evidence Reviewed [2026]
GLP-1 cohort studies link semaglutide to lower dementia risk, but the EVOKE trial failed. We grade the real evidence honestly for 2026.
Jun 25, 2026·
Trulicity (Dulaglutide) vs Ozempic: Weight Loss, A1C, and Dosing Compared [2026]
Trulicity vs Ozempic compared: SUSTAIN 7 head-to-head A1C and weight loss data, dosing, heart protection, side effects, and cost, with honest evidence grades.
Jun 25, 2026·
Liraglutide vs Semaglutide (Saxenda vs Wegovy): Head-to-Head Evidence [2026]
Liraglutide (Saxenda) vs semaglutide (Wegovy): STEP 8 head-to-head data, weight loss, heart benefits, cost, and which GLP-1 fits you in 2026.
Jun 25, 2026·
Do GLP-1s Raise Your Heart Rate? What the Evidence Shows [2026]
GLP-1 drugs raise resting heart rate by about 1-4 bpm. See what trials show, why it happens, when it matters, and how to monitor it safely.
Jun 25, 2026·